©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 13064-13073
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13064
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13064
Table 1 List of antimicrobial susceptibility testing results of Proteus vulgaris/penneri
| Code | Antimicrobial | Result | MIC |
| AMC | Amoxicillin/Clavulanic | Sensitivity | ≤ 4/2 |
| AMK | Amikacin | Sensitivity | ≤ 8 |
| AMP | Ampicillin | Resistance | 8 |
| ATM | Aztreonam | Sensitivity | ≤ 2 |
| CAZ | Ceftazidime | Sensitivity | ≤ 1 |
| CDR | Cefdinir | - | - |
| CEC | Cefaclor | - | - |
| CEP | Cephalothin | - | - |
| CFM | Cefixime | - | - |
| CFP | Cefoperazone | - | - |
| CHL | Chloramphenicol | Sensitivity | ≤ 4 |
| CID | Cefonicid | - | - |
| CIN | Cinoxacin | - | - |
| CIP | Ciprofloxacin | Sensitivity | 0.25 |
| CL | Colistin | Resistance | > 2 |
| CMZ | Cefmetazole | - | - |
| CPR | Cefprozil | - | - |
| CPX | Cefpodoxime proxetil | - | - |
| CRB | Carbenicillin | - | - |
| CRO | Ceftriaxone | - | - |
| CSL | Cefoperazone/Sulbactam | - | - |
| CTT | Cefotetan | - | - |
| CTX | Cefotaxime | Sensitivity | ≤ 1 |
| CXM | Cefuroxime | - | - |
| CZO | Cefazolin | Resistance | > 16 |
| CZX | Ceftizoxime | - | - |
| DOX | Doxycycline | - | - |
| ETP | Ertapenem | - | - |
| FEP | Cefepime | Sensitivity | ≤ 2 |
| FLE | Fleroxacin | - | - |
| FOS | Fosfomycin | - | - |
| FOX | Cefoxitin | - | - |
| GAT | Gatifloxacin | - | - |
| GEN | Gentamicin | Sensitivity | ≤ 2 |
| IPM | Imipenem | Sensitivity | ≤ 1 |
| KAN | Kanamycin | - | - |
| LOM | Lomefloxaccin | - | - |
| LOR | Loracarbef | - | - |
| LVX | Levofloxacin | Sensitivity | 0.5 |
| MAN | Cefamandole | - | - |
| MEC | Mecillinam | - | - |
| MEM | Meropenem | Sensitivity | ≤ 1 |
| MEZ | Mezlocillin | - | - |
| MFX | Moxifloxacin | Mediation | 4 |
| MNO | Minocycline | - | - |
| MOX | Moxalactam | - | - |
| NET | Netilmicin | - | - |
| NIT | Nitrofurantoin | - | - |
| NOR | Norfloxacin | - | - |
| OFX | Ofloxacin | - | - |
| PIP | Piperacillin | Sensitivity | ≤ 4 |
| SAM | Ampicillin-Sulbactam | Sensitivity | ≤ 4/2 |
| SSS | Sulfonamides | - | - |
| STR | Streptomycin | - | - |
| SXT | Trimethoprim-Sulfamethoxazole | Sensitivity | ≤ 0.5/9.5 |
| TCC | Ticarcillin/Clavulanic | - | - |
| TCY | Tetracycline | Resistance | ≤ 2 |
| TIC | Ticarcillin | - | - |
| TMP | Trimethoprim | - | - |
| TOB | Tobramycin | - | - |
| TZP | Piperacillin-Tazobactam | Sensitivity | ≤ 4/4 |
- Citation: Lu HY, Gao YB, Qiu XW, Wang Q, Liu CM, Huang XW, Chen HY, Zeng K, Li CX. Successful surgical treatment of polybacterial gas gangrene confirmed by metagenomic next-generation sequencing detection: A case report. World J Clin Cases 2022; 10(35): 13064-13073
- URL: https://www.wjgnet.com/2307-8960/full/v10/i35/13064.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i35.13064